Patiënten met kanker in het bloed, beenmerg of lymfeklieren (hematologische maligniteiten) die behandeld worden met stamceltransplantatie staan voor de uitdaging om te gaan met een levensbedreigende ziekte en een stressvolle behandeling. Een deel van de patiënten ervaart psychische klachten zoals angst …

Hematological malignancies and treatment with hematopoietic SCT are known to affect patients’ quality of life. The problem profile and care needs of this patient group need clarification, however. This study aimed to assess distress, problems and care needs after allo- or auto-SCT, and to identify risk …

Screening for psychological distress in patients with cancer is currently being debated in the British Journal of Cancer. Screening has been recommended, as elevated levels of distress have been consistently observed and clinicians tend to overlook the need of psychological support (Carlson et al, 2012; …

Identifying factors that predict health-related quality of life (QOL) following hematopoietic SCT, is important in estimating patients’ abilities to adjust to the consequences of their disease and treatment. As the studies that have been published on this subject are scattered, the present study aimed …